AURORA-GLIO
End-to-end stack for the most lethal primary brain tumor.
Glioblastoma and lower-grade gliomas remain the deadliest primary brain cancers. AURORA-GLIO unifies molecular profiling, radiomics, surgical planning, ethics and clinical translation into a single auditable, open pipeline.
Glioma is the most common malignant primary brain tumor in adults. Median survival in glioblastoma sits around 15 months despite four decades of trials. Heterogeneity — across patients and inside a single tumor — is the central problem AURORA-GLIO is built to address.
Research infrastructure that a named team can run inside its own perimeter, on research cohorts, and hand to the next team as a specification with running code.
Nothing in it diagnoses, triages, or produces output a clinician is expected to act on for an individual patient.
Each subsystem is a slice of the module with its own specification. Pick one to see what it does and how far it has been built. Module readiness overall: “Spec frozen · prototypes building”.
50 plain-language guides and 265 defined terms, with no methodology and no jargon left unexplained.
No AURORA module has entered this pathway. Every gate below reads not started, and will continue to until a real result is published and the site that produced it has agreed to be named. Build progress on the subsystems above is not evidence of clinical validity.
Held-out data from sites that took no part in development.
Runs alongside standard care with no output shown to clinicians.
Prospective, under ethics approval, reported to DECIDE-AI.
Continuous performance and drift tracking; degradation withdraws the module.